A detailed history of Marshall Financial Group LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Marshall Financial Group LLC holds 13,953 shares of NVO stock, worth $1.94 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
13,953
Previous 13,251 5.3%
Holding current value
$1.94 Million
Previous $1.37 Million 30.73%
% of portfolio
0.52%
Previous 0.45%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

BUY
$102.11 - $135.92 $71,681 - $95,415
702 Added 5.3%
13,953 $1.79 Million
Q4 2023

Jan 10, 2024

SELL
$87.78 - $105.45 $57,408 - $68,964
-654 Reduced 4.7%
13,251 $1.37 Million
Q3 2023

Oct 19, 2023

BUY
$90.94 - $199.54 $624,484 - $1.37 Million
6,867 Added 97.57%
13,905 $1.26 Million
Q2 2023

Jul 17, 2023

BUY
$155.98 - $172.65 $12,790 - $14,157
82 Added 1.18%
7,038 $1.14 Million
Q1 2023

Apr 18, 2023

SELL
$132.34 - $159.14 $399,666 - $480,602
-3,020 Reduced 30.27%
6,956 $1.11 Million
Q4 2022

Feb 01, 2023

SELL
$102.55 - $135.33 $9,024 - $11,909
-88 Reduced 0.87%
9,976 $1.35 Million
Q3 2022

Oct 12, 2022

SELL
$95.28 - $116.93 $7,527 - $9,237
-79 Reduced 0.78%
10,064 $1 Million
Q2 2022

Jul 25, 2022

SELL
$103.24 - $121.81 $220,933 - $260,673
-2,140 Reduced 17.42%
10,143 $1.13 Million
Q1 2022

May 10, 2022

BUY
$93.1 - $112.54 $4,375 - $5,289
47 Added 0.38%
12,283 $1.36 Million
Q4 2021

Jan 27, 2022

SELL
$95.88 - $117.08 $139,601 - $170,468
-1,456 Reduced 10.63%
12,236 $1.37 Million
Q3 2021

Oct 28, 2021

BUY
$84.42 - $106.62 $33,345 - $42,114
395 Added 2.97%
13,692 $1.32 Million
Q2 2021

Jul 14, 2021

SELL
$67.66 - $84.76 $90,055 - $112,815
-1,331 Reduced 9.1%
13,297 $1.11 Million
Q1 2021

Apr 20, 2021

BUY
$67.06 - $75.82 $53,983 - $61,035
805 Added 5.82%
14,628 $986,000
Q4 2020

Jan 29, 2021

BUY
$63.89 - $73.8 $883,151 - $1.02 Million
13,823 New
13,823 $966,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $313B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Marshall Financial Group LLC Portfolio

Follow Marshall Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Financial Group LLC with notifications on news.